Conference abstractPublished 5 Sep 2011
Construction of new infectious molecular clones (IMC) expressing Renilla Luciferase (IMCLucR) for HIV neutralization assay standardization
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Standardized assays to assess vaccine and antiviral drug effi cacy are key to the HIV fi eld. Th e main requirements for immunological assays (e.g., antibody neutralization and antibodydependent cellular cytotoxicity (ADCC) are the use of natural HIV target cells such as peripheral blood mononuclear cell (PBMC), and the use of HIV-1 infectious molecular clones (IMC) that i) express a reporter gene, ii) are representative of diff erent genetic clades and iii) are engineered to express heterologous envelope gene representating diff erent genetic clades. Th us far, only a clade B laboratory-adapted strain IMC was developed using these approaches; moreover, only a portion of the gp160 coding sequence is swapped. Here we described the construction of three native IMC expressing the Renilla Luciferase (LucR) gene from a Circulating Recombinant Form CRF01_AE, a clade B and a clade C; all three infect cell lines as well as primary cells. Each of these constructs was engineered to swap the full envelope gene, allowing gp160 to be expressed in its native form. Our data showed infection in TZMbl cells - one of the most common cell line used for infection neutralization assays - and a majority of them infected PBMC also. Neutralization data was also generated and diff erences where observed when compared with the commonly used pseudovirus assay. In addition, some envelopes showed diff erent neutralization profi les when expressed in homologous- vs heterologous-HIV chimeric clade. Th ese data highlight the importance of using infectious molecular clones as reagent in neutralization assay for assessing HIV-1 vaccine immunogen effi cacy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Agn�s-Laurence Chenine”
